Wayne Linsley - 29 Dec 2021 Form 4/A - Amendment Insider Report for Silo Pharma, Inc. (SILO)

Role
Director
Signature
/s/ Wayne Linsley
Issuer symbol
SILO
Transactions as of
29 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Jan 2022, 17:18:55 UTC
Date Of Original Report
03 Jan 2022
Previous filing
30 Sep 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILO Non-Qualified Stock Option Award $0 +171,233 $0.000000 171,233 29 Dec 2021 Common Stock 171,233 $0.1460 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over the course of one year from grant with 100% vesting a year from the date of grant.
F2 The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan.
F3 This Form 4/A deletes the second Non-Qualified Stock Option for 171,233 shares erroneously reported in the original Form 4 filed on January 3, 2022.